Personalized Medicine

Vanderbilt University Medical Center (VUMC) has been chosen by the National Institutes of Health (NIH) to be the Data and Research Support Center for the Precision Medicine Initiative Cohort Program, a landmark study of genetic, environmental and lifestyle factors affecting the health of a million or more people, federal officials have announced. Read More

A new clinical implementation study from Vanderbilt University Medical Center measures how physicians have responded to the introduction of routine genetic testing to predict patient response to the commonly prescribed antiplatelet drug clopidogrel. Read More

Enrollment has opened for Case Studies in Personalized Medicine, Vanderbilt's latest free massive open online course, or MOOC. The six-week course starts Jan. 15. Read More

Vanderbilt University researchers next month will launch a major initiative to acquire “dense genotypes” from 100,000 individuals whose medical histories are known. Read More

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given. Read More

Vanderbilt University has received a five-year grant from the National Institutes of Health (NIH) to establish the Tennessee Center for AIDS Research with Meharry Medical College and the Tennessee Department of Health. Read More

More than 100 clinician-scientists, geneticists, biomedical informatics experts, bio-statisticians, policy experts and students gathered for Personalized Medicine Day on May 1 at the Student Life Center. The depth and breadth of Vanderbilt’s ongoing investment in personalized medicine was on display in lectures, panel discussions and poster sessions. Read More

Vanderbilt faculty and staff are invited to attend Personalized Medicine Day on Friday, May 1, 8 a.m. to 4 p.m. at the Vanderbilt University Student Life Center. Read More

Josh Denny, M.D., M.S., associate professor of Biomedical Informatics and Medicine, will help guide planning for the precision medicine initiative announced by President Obama in his January State of the Union Address. Read More

The Precision Medicine Initiative is a national effort announced by President Obama during his State of the Union address to provide more effective treatment and prevention strategies for individuals by taking into account their unique genetic, environmental and lifestyle factors. Read More

During the past five years, Vanderbilt University Medical Center has become a leader in “personalized medicine,” the use of genomic information to individualize patient care. Read More

Dan Roden, M.D., assistant vice chancellor for Personalized Medicine, has been appointed to the National Advisory Council for Human Genome Research of the National Institutes of Health (NIH). Read More

A genetic variant is associated with toxicity of the chemotherapy drug melphalan, and could guide individualized dosing for the medication. Read More

Electronic medical records linked to DNA biobanks are a valid resource for defining and understanding the genetic factors that contribute to drug response. Read More

Tacrolimus is essential for patients receiving new hearts, kidneys and other organ transplants. The drug suppresses the body’s immune system, helping to prevent rejection. Read More

VUMC’s personalized medicine effort is getting a major boost with the recruitment of two physician-scientists from Australia who will increase Vanderbilt’s strength in translational immunology, the translation of basic immunological discoveries into clinically useful tools. Read More

The One Vanderbilt transformation continues as Nicholas S. Zeppos marks five years as chancellor. Read the story and watch video of Zeppos discussing the opportunities and challenges facing Vanderbilt today. Read More

L-r: Raymond DuBois, Jeff Balser and Dan Roden. (Steve Green/Vanderbilt) “Personalized medicine—the effort to tailor health care to understand individual patients’ needs, genetic profiles and circumstances—is a big emphasis at the Vanderbilt University Medical Center,” said Jeff Balser, vice chancellor for health affairs and dean of… Read More

During a meeting in Nashville last week, the director of the National Institutes of Health (NIH) called on academic medical centers to make the case for continued, strong federal investment in biomedical research. Read More

Watch video of the Chancellor’s Lecture Series, featuring a talk by Dr. Dan Roden: “Genomes, Hype, and a Realistic Pathway to Personalized Medicine” Roden is widely-recognized for his expertise in clinical, genetic, cellular, and molecular basis of arrhythmia susceptibility and variability responses to arrhythmia therapies. Over the past decade, he… Read More